Segment Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,173
Closed -$305K 223
2022
Q1
$305K Sell
4,173
-255
-6% -$17.1K 0.03% 209
2021
Q4
$276K Buy
+4,428
New +$260K 0.03% 215
2021
Q3
Sell
-3,192
Closed -$213K 229
2021
Q2
$213K Buy
+3,192
New +$208K 0.03% 218
2020
Q1
Sell
-4,133
Closed -$265K 190
2019
Q4
$265K Buy
+4,133
New +$237K 0.04% 203
2018
Q4
Sell
-9,792
Closed -$608K 183
2018
Q3
$608K Sell
9,792
-19
-0.2% -$1.13K 0.13% 118
2018
Q2
$543K Sell
9,811
-167
-2% -$9.02K 0.13% 123
2018
Q1
$631K Hold
9,978
0.16% 112
2017
Q4
$611K Sell
9,978
-518
-5% -$32.4K 0.15% 117
2017
Q3
$669K Buy
10,496
+3,678
+54% +$215K 0.18% 106
2017
Q2
$380K Buy
6,818
+274
+4% +$14.9K 0.1% 140
2017
Q1
$356K Buy
6,544
+319
+5% +$17.5K 0.12% 128
2016
Q4
$364K Hold
6,225
0.13% 114
2016
Q3
$336K Hold
6,225
0.13% 114
2016
Q2
$458K Buy
6,225
+925
+17% +$65.4K 0.19% 94
2016
Q1
$339K Buy
5,300
+100
+2% +$6.31K 0.13% 106
2015
Q4
$358K Hold
5,200
0.14% 105
2015
Q3
$308K Hold
5,200
0.12% 117
2015
Q2
$346K Hold
5,200
0.12% 120
2015
Q1
$335K Hold
5,200
0.11% 124
2014
Q4
$307K Sell
5,200
-147
-3% -$8.29K 0.12% 113
2014
Q3
$274K Sell
5,347
-10
-0.2% -$500 0.1% 139
2014
Q2
$260K Buy
5,357
+157
+3% +$7.74K 0.1% 148
2014
Q1
$270K Hold
5,200
0.13% 132
2013
Q4
$276K Hold
5,200
0.14% 124
2013
Q3
$241K Sell
5,200
-168
-3% -$7.38K 0.13% 129
2013
Q2
$240K Buy
+5,368
New +$233K 0.14% 125

Other funds holding BMY

Segment Wealth Management's BMY Position: Q2 2022 in Review

Segment Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 4,173 shares — an estimated $305K sold.

Segment Wealth Management first reported a position in BMY in Q2 2013 and held it in 26 quarters. The position peaked at $669K in Q3 2017. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Segment Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • Segment Wealth Management sold 4,173 Bristol-Myers Squibb shares in Q2 2022, an estimated $305K.
  • Segment Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 26 quarters.
  • Segment Wealth Management's Bristol-Myers Squibb position peaked at $669K in Q3 2017.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Segment Wealth Management's 13F filing for Q2 2022, filed 20 Jul 2022.